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Abstract 
 The treatment success of attention-deficient/hyperactivity disorder 
(ADHD) is limited by misdiagnosis or underestimated co-existing 
conditions, including epilepsy, mental retardation, and autism spectrum 
disorder. The aim of this study was to document the prevalence of these three 
ADHD co-morbidities in a single patient population. A total of 107 children 
(3-12 years)   evaluated for ADHD in our neurology clinic (clinical sample) 
were initially considered for this study. The existence of co-morbidities was 
determined using parent interview, family history, medical history, 
developmental history, and neurological evaluation. Results showed that 82 
patients (M:F; 60:22) fulfilled the criteria for ADHD diagnosis. The patient 
population was composed of combined ADHD (51%), hyperactive/impulsive 
(28%). and inattentive (21%), Boys were about three times more likely to 
present with combined or hyperactive/impulsive ADHD compared to girls. 
Among all ADHD children, 70% presented co-morbidity: epilepsy ((29.3%), 
mental retardation (28%) or autistic spectrum disorder (12.2%). Such 
common occurrence suggests that the current protocols used to diagnose 
ADHD should be refined to identify these co-morbidities for the 
development of a new approach to ADHD. Our  findings add relevant 
clinical information on ADHD from a world region where few clinical 
studies on this disorder have thus far been conducted. 
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Introduction 
Attention-deficient/hyperactivity disorder (ADHD) is a syndrome 
characterized by three types of symptoms; inattention, hyperactivity, and 
impulsivity (Reiff et al. 1993; Barkley 1996). It is a common 
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neurobehavioral disorder affecting school-aged children (Shooshtary et al. 
2010). The Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition (DSM-IV) criteria define three subtypes of ADHD: inattentive, 
hyperactive-impulsive, and combined type (APA-1994). 
ADHD symptoms present during childhood but often continue into 
adolescence (Biederman et al. 1996). As a result, children with ADHD may 
experience significant functional problems, such as difficulty in school and 
academic underachievement (Zentall 1993), troublesome interpersonal 
relationships with family members and peers (Schachar 1987; Almond et al. 
1999), and low self-esteem. Individuals with ADHD present in childhood 
continue to show symptoms of mental disorders such as oppositional defiant 
conduct, depression, and anxiety in adolescence. It is also associated with 
many developmental and neurocognitive disorders that share common 
manifestations (August 1996).  
ADHD and epilepsy are both common childhood disorders (Reilly CJ 
2011). DSM-5 includes no exclusion criteria for people with autism 
spectrum disorder, since symptoms of both disorders co-occur. Because they 
share symptoms with ADHD, these co-morbidities may seriously interfere 
with the design of effective treatments. Children with epilepsy may manifest 
symptoms of ADHD, whereas children with ADHD may develop epilepsy. 
Some antiepileptic drugs such as phenobarbitone, gabapentin, topiramate, 
and levetiracetam, may not be helpful in controlling behavioral symptoms of 
ADHD. Stimulants are the main stay of pharmacotherapy for ADHD but 
there is a risk of decreasing seizure threshold in children with co-morbid 
epilepsy especially when their epilepsy is not well controlled. Existing 
evidence is not in favor of screening children with ADHD for an EEG 
abnormality before starting stimulant therapy (Kattimani S. 2011). 
Recent studies suggest that ADHD is a common co-morbid condition 
in childhood epilepsy (Cohen R, et al.).ADHD is significantly more 
prevalent in new onset epilepsy than healthy controls (31%  VS 6%) 
(Hermann B  2007). To our knowledge, no study has documented the 
prevalence of ADHD, epilepsy, mental disorders, and autistic spectrum 
disorder (ASD) in a single population. This is the first study to document the 
prevalence of all 3 major types of ADHD co-morbidity: epilepsy, mental 
retardation, and autism spectrum disorder in the same patient population. 
Findings of this study may lead to the development of new intervention 
approaches to this disorder.   
Therefore, the aim of this study was to compare the prevalence of 
epilepsy, mental retardation, and ASD in children diagnosed with ADHD 
and to assess ADHD manifestations in children suffering with these three 
neurological conditions, as well as to increase awareness of clinicians to 
consider these co-morbidities in the evaluation of children having ADHD. 
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This study comes from a world region where little clinical research 
on this disorder has been conducted. 
Study Design and Methods 
A total of 107 children visiting any of the two pediatric neurology 
clinics in Al karak city of South Jordan during the period of October 2009 to 
2011 for consultation regarding manifestations of ADHD were recruited in 
this study. Inclusion criteria for each child was to have one or combination of 
hyperactivity, inattention, or impulsivity. The DSM-IV diagnosis 
of ADHD requires the presence of six of nine items or features that must 
have been present for at least six months and to have had an onset before 7 
years of age (Tan M. 2005). All children were accompanied by their parents. 
During their visit, complete details on developmental (antenatal, natal, and 
post-natal), medical, and family history were recorded.  General and 
neurological examinations were performed for all children, and 
investigations such as brain CT or EEG were conducted when indicated.  A 
SWAN rating scale for ADHD validated by James Swanson (Swanson 2012) 
including all DSM-IV criteria were completed by the mothers of all 
participants for the diagnosis of ADHD. An informed consent was obtained 
from all the parents before the questionnaire was administered. 
Epilepsy was diagnosed clinically and by conducting 
electroencephalography [EEG] and neuroimaging examination when 
indicated. 
Statistical analysis 
Frequency, valid percentage, mean, and SD were reported for all the 
variables appropriately. Chi square test was performed for comparing non-
categorical variables among the groups. A p value of <0.05 was considered 
statistically significant.  
Results  
Of the 107 subjects manifesting symptoms of ADHD and examined 
at the clinic, only 82 (76.6 %) met the criteria for ADHD. Among these 
patients, 60 (73.2 %) were male and 22 (26.8%) were female  
 Male to female ratio was found to be significantly different for 
hyperactive impulsive type (p = 0.003) compared to other groups. For the 
combined subtype, the male to female ratio was significantly different (p = 
0.008). The total male to female ratio for all children (60:22) also differed 
significantly (p = 0.00004). There was no statistically significant difference 
observed in the male and female ratio for the inattentive subtypes (p = 0.4) 
(Table 
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Table 1: ADHD subtypes, male /female distribution, and ratios using Chi square test. 
Sub type Number 
of 
Cases 
% Male % Female % Ratio Chi 
square 
P value 
Inattentive 17 20.7 10 58.8 7 41.2 1.43:1 0.53 0.4 
H.I 23 28 18 78.2 5 21.7 3.6:1 7.35 0.003 
Combined 42 51.2 32 76.3 10 23.8 3.2:1 6.76 0.008 
Total 82  60  22  2.9:1 12.6 0.00004 
 
Among patients who met the criteria, the combined subtype was the 
most common, representing (51.2%) of all cases. The hyperactive-impulsive 
and inattentive subtypes were diagnosed in 28 and 27.2% of patients, 
respectively. More than 29% of the patients in this study had both epilepsy 
and ADHD. Prevalence of mental retardation was 28% among patients in 
this study. Ten patients (12.2%) had ASD and prominent features of ADHD. 
On comparing gender against morbidity, it was found that only the 
association of ASD to male gender was significantly different (p = 0.014) 
(Table 2). 
Table 2: Co-morbidities versus gender 
Co morbidity Total Male Female Chi square p value 
Epilepsy 24 15 9 1.5 0.2 
M.R 23 14 9 1.15 0.3 
ASD 10 9 1 6.4 0.14 
 
Regarding co-morbidities versus subtype, we found that there was an 
association between co-morbidities and all subtypes of ADHD; however, it 
was significant only with the combined subtype (p = 0.012) for epilepsy and 
mental retardation (p = 0.008) for ASD (Table 3). 
Table 3: Co-morbidities and their correlation to subtypes 
 Total Inattentive Hyperactive 
impulsive 
Combined Chi 
square 
P value 
Epilepsy 24 3 8 13 6.25 0.012 
M.R. 23 6 5 12 6.25 0.012 
ASD 10 0 3 7 7.56 0.008 
 
Discussion 
The rate of ADHD diagnosis among children has increased over time 
(Getahun D 2013). However, we now face the troubling reality that ADHD 
may be complicated by additional complications with common symptoms. 
The present study was designed to test the prevalence of epilepsy, mental 
retardation (MR) and autistic spectrum disorder (ASD) in a patient 
population presenting with ADHD manifestations.  
Male to female ratios were similar to the figures commonly reported 
for this syndrome [overall prevalence of current DSM-IV-like ADHD was 
9.2% with a male:female ratio of 2.28:1] (Ramtekkar et al. 2010). The 
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number of males was almost three times as great as the number of females 
(2.9:1) in our study population. The male to female ratios for the 
hyperactive-impulsive (3.6:1) and combined (3.2:1) subtypes were also 
similar to ratios reported in the literature. Although there was also a larger 
number of males with the inattentive subtype, the male to female ratio 
(1.43:1) was lower than that observed for the other subtypes.  
The predominance of Combined ADHD has been reported in other 
countries (Wang et al. 2011; Chiang et al. 2010). Furthermore, boys were 
three times more likely to develop ADHD, especially in the Combined or 
hyperactive/impulsive subtypes. These data are consistent with the male 
predominance (70%) reported for 88 hyperactive/ impulsive ADHD patients 
in the US (Miller et al. 2010). In Greece, the estimated prevalence of ADHD 
was 8% for boys and 3.8% for girls (Skounti et al. 2010). Overall, these data 
demonstrate that the patient population included in the present study is 
representative of the global situation, with a predominance of boys 
diagnosed with Combined ADHD. 
Over twenty-three percent of children that reported to the 
neurological clinic with ADHD manifestations failed to fulfill the criteria for 
the disorder, as established by the DSM-IV. This discrepancy can be 
explained by several factors. First, some children had ADHD manifestations 
but fulfilled only 5 of 9 behavioral criteria. Overprotection by the mothers 
likely contributed to this.   
ADHD and epilepsy 
  Epilepsy and attention-deficit hyperactivity disorder (ADHD) were 
reported to co-occur at rates higher than expected for coincidental findings 
(Cohen R, 2013). Population studies suggest that the prevalence of ADHD in 
patients with childhood epilepsy is between 12 and 17%. Several factors may 
account for this positive association. These include common genetic 
propensity, noradrenergic system dysregulation, subclinical epileptiform 
discharges, seizures, antiepileptic drug effects and psychosocial factors 
(Reilly 2011).  
Population studies support the common occurrence of ADHD and 
epilepsy co-morbidity. A review of literature between 1990−2010 reported 
20−40% ADHD children to be epileptic (Kattimani & Mahadevan 2011). 
These data are consistent with the present study reporting 29% of ADHD 
children to be epileptic. Furthermore, we documented the incidence of 
epilepsy morbidity in the three types of ADHD. As commonly reported for 
ADHD patients, more than 50% of the patients with co-morbidity belonged 
to the combined ADHD group. In contrast, epilepsy co-morbidity was very 
low in Inattentive ADHD patients. Epileptic children may manifest 
symptoms of ADHD due to a lifetime depression and anxiety, as well as 
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from seizure and brain damage (Titlic 2009). Further, children with ADHD 
are predisposed to epileptic seizure (Hesdorffer et al. 2004).  
 In addition, a strong trend towards a higher prevalence of epilepsy 
among children with ADHD is observed compared to those without ADHD. 
Epilepsy in children with ADHD appears to be more severe than those 
without ADHD (Davis et al. 2010). This co-condition raises issues regarding 
diagnostics and medications. Stimulants are the mainstay of 
pharmacotherapy in ADHD. But there is low risk of promoting seizures in 
children with co morbid epilepsy.  
ADHD and mental retardation 
  Children with milder forms of mental retardation may escape 
detection until their school years, when parents or teachers begin to 
recognize symptoms or learning disabilities and bring them to a pediatrician 
for evaluation. Until recently, physicians did not believe that ADHD 
occurred in children with mental retardation, but assumed that these 
children’s hyperactive or other ADHD-type behavior was simply a 
manifestation of mental retardation. As a result, stimulant medications were 
rarely prescribed, and ADHD was left untreated.  A study by Das JP et al 
reported 33% of junior and senior high school students with mild MR had 
ADHD (Das & Melnyk 1989). Population studies suggest that mental 
retardation may be 5-10 times as common in ADHD as in children without 
ADHD [Kadesjo B. Gillberg C (2001), Pliszka SR (2000)] 
  In our study, mental retardation was determined based on the 
Stanford Binet intelligence test in those children who had been removed 
from mainstream classrooms, or with parents considering that the child was 
unfit for school. Based on these criteria, the incidence of mental retardation 
(28%) among patients in this study falls near the lower end of this range. We 
also observed a higher incidence in males, which is likely explained by the 
higher prevalence of this syndrome within this sex, and over half (52.5%) of 
the MR cases occurred in patients with the combined subtype.  
ADHD and ASD 
In a recent review, Kolevzon (Kolevzon 2007) noted that symptoms 
of attention deficit, impulsiveness, and hyperactivity are relatively common 
among individuals with ASD. Similar findings were acknowledged by 
Kanner et al in his original description of the symptomatology associated 
with autism. In a recent survey of 487 children and adolescents with ASD, 
more than 50% had moderate-to-severe symptoms of inattention and 
hyperactivity (Lecavalier 2006). In another sample of 101 children with 
ASD, 95% exhibited attention deficit, 50% demonstrated impulsive 
behavior, and 75% had symptoms consistent with ADHD (Reiersen et al. 
2007).  Overall, it is estimated that ADHD occurs in the range of 14−80% of 
patients with ASD. While ADHD is not a core symptom, the manifestations 
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of ADHD can be even more debilitating for patients with both disorders 
(Goldstein & Schwebach 2004). DSM-5 includes no exclusion criteria for 
people with autism spectrum disorder, since symptoms of both disorders co-
occur. 
In the present study, symptoms of attention deficit, impulsivity, and 
hyperactivity were common among individuals diagnosed with ASD. Ten 
patients (12.2%) had ASD and prominent features of ADHD. Of these, nine 
of them were males. The ratio of males to females with both disorders is 
much higher than the usual 4:1. Regarding subtypes, 70% of cases occurred 
in individuals with the combined subtype, and the remaining 30% were 
observed in individuals with the hyperactive-impulsive subtype.  
The relationship between ADHD and childhood epilepsy, mental 
retardation and autistic spectrum disorder is complex. Numerous factors 
contribute to variation in estimates of prevalence and obscure relationships 
between these disorders. This study demonstrates the high prevalence of 
ADHD co-morbidities in Jordanian children.  
Limitations in this study include the fact that these children were 
transferred to a pediatric neurology clinic due to ADHD manifestations, 
school failure, learning difficulties, behavioral disorders (ASD) and epilepsy. 
In other words, it is not a true group of ADHD patients (population study) 
but it is rather a clinical sample with a variety of neurological conditions 
having in common ADHD manifestations.  
Conclusions 
This is the first study to document the prevalence of all 3 major types 
of ADHD co-morbidity in the same patient population. Among all ADHD 
children, 70% presented co-morbidity as follows: epilepsy (29.3%), mental 
retardation (28%) or autistic spectrum disorder (12.2%). The present study 
demonstrates the common occurrence of co-morbidities in all three subtypes 
of ADHD, namely epilepsy, mental retardation, and autism spectrum 
disorder and their significant association with the combined subtypes. Since 
these conditions are associated with the diagnostic and treatment strategies of 
ADHD, it is adamant that clinicians routinely consider the possibility of co-
morbidities in their diagnosis of ADHD, especially in the combined 
subtypes. This study is particularly important to our understanding of this 
condition because is originates from a world region where little clinical 
research on this disorder have been conducted. 
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